bpc-157 local injection near injury site evidence Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 for Wrist Injuries: Tendon
BPC 157 for Wrist Injuries: Tendon & Ligament Healing Guide What is BPC 157 and why are athletes combining it with GLP 1s? BPC 157: Benefits, Dosing & Side Effects (2026) Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle to Bone Reattachment in Rats
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15


